| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 16.35B | 15.57B | 20.52B | 15.53B | 18.54B |
| Gross Profit | 3.44B | 3.56B | 7.55B | 4.15B | 5.57B |
| EBITDA | 5.46B | 5.10B | 9.42B | 9.54B | 13.22B |
| Net Income | 2.25B | 2.87B | 1.90B | 1.35B | 3.67B |
Balance Sheet | |||||
| Total Assets | 152.33B | 136.00B | 130.49B | 133.49B | 123.71B |
| Cash, Cash Equivalents and Short-Term Investments | 13.60B | 9.98B | 9.78B | 16.86B | 12.03B |
| Total Debt | 70.99B | 61.38B | 56.35B | 57.21B | 54.97B |
| Total Liabilities | 89.69B | 81.47B | 75.52B | 78.30B | 60.66B |
| Stockholders Equity | 35.58B | 32.50B | 31.58B | 31.25B | 41.20B |
Cash Flow | |||||
| Free Cash Flow | -5.50B | -5.41B | -4.49B | 2.90B | -4.41B |
| Operating Cash Flow | 4.51B | 4.38B | 5.55B | 10.13B | 3.67B |
| Investing Cash Flow | -11.13B | -5.64B | -6.47B | -7.84B | -8.15B |
| Financing Cash Flow | 6.74B | 2.71B | -2.05B | -444.80M | 8.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$6.64B | 13.69 | 5.90% | 5.26% | 12.06% | -19.10% | |
71 Outperform | HK$66.79B | 9.84 | 11.38% | 5.43% | -16.77% | -1.46% | |
69 Neutral | HK$30.40B | 10.82 | 15.24% | 5.08% | -5.31% | 10.69% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | HK$18.16B | 9.34 | 6.54% | 6.96% | 4.98% | -22.67% | |
55 Neutral | HK$24.13B | -12.81 | 4.58% | 3.72% | 4.71% | -4.62% | |
52 Neutral | HK$20.46B | 14.25 | 7.59% | 5.82% | -16.28% | -1.83% |